A Lafayette father's battle with stage 4 pancreatic cancer is taking a hopeful turn as he becomes the first in Colorado to receive a newly approved targeted therapy.
Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
More than 10,000 Americans who suffer from chronic liver disease are on a waitlist for a liver transplant, but there are not ...
Cambridge scientists have shown that when tumors first emerge, interactions with healthy cells in the underlying supportive tissue determine their ability to survive, grow, and progress to advanced ...
David Lyon, now 31, was diagnosed with stage 4 colon cancer at 26. For March's Colorectal Cancer Awareness Month, he's urging ...
Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve chronic disease outcomes for ...
Background Concomitant metabolic dysfunction-associated steatotic liver disease (MASLD) is prevalent in patients with chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results